Argent BioPharma Limited (RGT.L)
GBp 6.0
(-7.69%)
GBp 6.0
(-7.69%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 891.08 Thousand | 1.77 Million | 2.68 Million | 1.62 Million | 1.15 Million | 361.84 Thousand |
| Cost of Revenue | 687.38 Thousand | 1.41 Million | 1.79 Million | 1.22 Million | 1.32 Million | 339.86 Thousand |
| Gross Profit | 203.69 Thousand | 366.62 Thousand | 885.67 Thousand | 400.24 Thousand | -170.76 Thousand | 21.97 Thousand |
| Operating Expenses | 18.46 Million | 8.49 Million | 8.2 Million | 5.98 Million | 6.4 Million | 5 Million |
| Selling, General and Administrative Expenses | 11.08 Million | 7.36 Million | 6.56 Million | 3.96 Million | 3.41 Million | 2.96 Million |
| Research and Development Expenses | 2.32 Million | 1.04 Million | 1.54 Million | 1.95 Million | 2.99 Million | 2.04 Million |
| Other Expenses | 5.05 Million | -86.16 Thousand | -94.29 Thousand | -69.67 Thousand | -1.72 Million | - |
| Cost and Expenses | 19.15 Million | 9.9 Million | 9.99 Million | 7.21 Million | 7.73 Million | 5.34 Million |
| Operating Income | -18.26 Million | -8.12 Million | -7.31 Million | -5.58 Million | -6.57 Million | -4.98 Million |
| Interest Expense | 482.47 Thousand | 257.4 Thousand | 210.14 Thousand | 369.13 Thousand | 135.58 Thousand | 244.82 |
| Income Tax Expense | - | 1058.84 | -238.33 Thousand | -290.48 Thousand | -239.27 Thousand | -165.55 Thousand |
| Earnings before Tax | -17.54 Million | -11.08 Million | -11.77 Million | -8.91 Million | -10.69 Million | -6.26 Million |
| Net Income | -17.53 Million | -10.92 Million | -11.53 Million | -8.62 Million | -10.78 Million | -4.73 Million |
| Earnings Per Share Basic | -0.47 | -3.71 | -4.50 | -4.53 | -7.81 | -3.91 |
| Earnings Per Share Diluted | -0.47 | -3.71 | -4.50 | -4.53 | -7.81 | -3.91 |
| Weighted Average Shares Outstanding | 37.01 Million | 2.94 Million | 2.56 Million | 1.9 Million | 1.38 Million | 1.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.01 Million | 2.94 Million | 2.56 Million | 1.9 Million | 1.38 Million | 1.2 Million |
| Gross Margin | 0.23 | 0.21 | 0.33 | 0.25 | -0.15 | 0.06 |
| EBIT Margin | -17.70 | -4.35 | -2.64 | -3.22 | -5.45 | -13.38 |
| Profit Margin | -19.67 | -6.15 | -4.30 | -5.30 | -9.31 | -13.07 |
| EBITDA | -15.77 Million | -7.73 Million | -20.3 Million | -5.23 Million | -6.3 Million | -1.6 Million |
| Earnings Before Tax Margin | -20.49 | -4.57 | -2.73 | -3.43 | -5.68 | -13.77 |
| Breakdown | 2023 Q4 | 2022 FY | 2023 Q2 | 2022 Q4 | 2021 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 320.62 Thousand | 1.77 Million | 380.36 Thousand | 1.5 Million | 2.68 Million | 1.22 Million |
| Cost of Revenue | 632.09 Thousand | 1.41 Million | 465.19 Thousand | 895.71 Thousand | 1.79 Million | 596.82 Thousand |
| Gross Profit | -311.47 Thousand | 366.62 Thousand | -84.82 Thousand | 604.45 Thousand | 885.67 Thousand | 631.1 Thousand |
| Operating Expenses | 3.18 Million | 8.49 Million | 3.59 Million | 4.16 Million | 8.2 Million | 5 Million |
| Selling, General and Administrative Expenses | 3.18 Million | - | 3.59 Million | 4.16 Million | - | 4.03 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -86.16 Thousand | - | - | -94.29 Thousand | -971.16 Thousand |
| Cost and Expenses | 3.81 Million | 9.9 Million | 4.06 Million | 5.06 Million | 9.99 Million | 5.6 Million |
| Operating Income | -3.49 Million | -8.12 Million | -3.68 Million | -3.56 Million | -7.31 Million | -4.37 Million |
| Interest Expense | 249.56 Thousand | 257.4 Thousand | 80.29 Thousand | 58.8 Thousand | 210.14 Thousand | 55.4 Thousand |
| Income Tax Expense | -9451.00 | 1058.84 | 35.15 | 1099.22 | -238.33 Thousand | -144.15 Thousand |
| Earnings before Tax | -3.79 Million | -11.08 Million | -5.27 Million | -6.23 Million | -11.77 Million | -7.46 Million |
| Net Income | -3.78 Million | -10.92 Million | -5.21 Million | -6.13 Million | -11.53 Million | -7.31 Million |
| Earnings Per Share Basic | -0.12 | - | -0.16 | -2.14 | - | -2.68 |
| Earnings Per Share Diluted | -0.12 | - | -0.16 | -2.14 | - | -2.68 |
| Weighted Average Shares Outstanding | 45.28 Million | 2.94 Million | 23.09 Million | 2.86 Million | 2.56 Million | 2.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.28 Million | 2.94 Million | 23.09 Million | 2.86 Million | 2.56 Million | 2.72 Million |
| Gross Margin | -0.97 | 0.21 | -0.22 | 0.40 | 0.33 | 0.51 |
| EBIT Margin | -9.80 | - | -9.15 | -2.31 | - | -3.49 |
| Profit Margin | -11.80 | -6.15 | -13.71 | -4.09 | -4.30 | -5.96 |
| EBITDA | -3.14 Million | - | -3.48 Million | -3.47 Million | - | -4.28 Million |
| Earnings Before Tax Margin | -10.89 | -4.57 | -9.68 | -2.37 | -2.73 | -3.56 |
7040
CNE
CAC
MNAT
RADHIKAJWE
SIAM